OrsoBio raises $60m to advance treatment for obesity
OrsoBio has raised $60m in Series A financing to advance its metabolic portfolio for the treatment of obesity and associated disorders.
Fast, Ad-Free News Updates
Stay updated with breaking news from Edd Fleming. Real-time updates on events, politics, business and more.